Literature DB >> 21120487

Candidate gene studies of fibromyalgia: a systematic review and meta-analysis.

Young Ho Lee1, Sung Jae Choi, Jong Dae Ji, Gwan Gyu Song.   

Abstract

The aim of this study was to explore whether the candidate gene polymorphisms contribute to fibromyalgia susceptibility. The authors conducted a meta-analysis on associations between serotonin transporter (5-HTT) gene-linked polymorphic region (5-HTTLPR) S/L allele, catechol-O-methltransferase (COMT) val158Met, and serotonin 2A (5-HT2A) receptor 102T/C polymorphisms and fibromyalgia susceptibility as determined using the following: (1) allele contrast, (2) recessive, (3) dominant models, and (4) contrast of homozygotes. We also performed a systematic review with available data of the candidate genes. A total of 21 separate comparisons were considered in this systematic review and meta-analysis. Seventeen candidate genes and over 35 different polymorphisms were identified in studies on fibromyalgia susceptibility. Meta-analysis of the 5-HTTLPR S/L allele and COMT val158Met failed to reveal any association with fibromyalgia. However, meta-analysis of the C allele, CC + CT genotype, and CC versus TT genotype of the 5-HT2A receptor 102T/C polymorphism showed significant association with fibromyalgia. The overall OR of the association between the C allele and fibromyalgia was 1.333 (95% CI = 1.053-1.688, P = 0.017). The ORs for the CC + CT genotype, and CC versus TT genotype showed the same pattern as that observed for the C allele (OR = 1.541, 95% CI = 1.032-2.303, P = 0.035; OR = 1.838, 95% CI = 1.151-2.936, P = 0.011). This meta-analysis demonstrates that the 5-HT2A receptor 102T/C polymorphism confers susceptibility to fibromyalgia. In contrast, no association was found between the 5-HTTLPR S/L allele, COMT val158Met, and susceptibility to fibromyalgia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21120487     DOI: 10.1007/s00296-010-1678-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  42 in total

1.  Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5- HTTLPR) polymorphism, and relationship to anxiety-related personality traits.

Authors:  Hagit Cohen; Dan Buskila; Lily Neumann; Richard P Ebstein
Journal:  Arthritis Rheum       Date:  2002-03

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

3.  Association of T102C polymorphism of the 5-HT2A receptor gene with psychiatric status in fibromyalgia syndrome.

Authors:  S Gürsoy; E Erdal; H Herken; E Madenci; B Alaşehirli
Journal:  Rheumatol Int       Date:  2001-10       Impact factor: 2.631

4.  Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome.

Authors:  Savaş Gürsoy; Emin Erdal; Hasan Herken; Ercan Madenci; Belgin Alaşehirli; Nurten Erdal
Journal:  Rheumatol Int       Date:  2002-10-22       Impact factor: 2.631

5.  Mutational analysis of serotonin receptor genes: HTR3A and HTR3B in fibromyalgia patients.

Authors:  Bernd Frank; Beate Niesler; Brigitta Bondy; Michael Späth; Dieter E Pongratz; Manfred Ackenheil; Christine Fischer; Gudrun Rappold
Journal:  Clin Rheumatol       Date:  2004-05-07       Impact factor: 2.980

6.  The association between fibromyalgia and polymorphism of monoamine oxidase A and interleukin-4.

Authors:  Shan-Yu Su; Jonathan Jiunn-Horng Chen; Chien-Chen Lai; Chun-Ming Chen; Fuu-Jen Tsai
Journal:  Clin Rheumatol       Date:  2006-03-18       Impact factor: 2.980

7.  Which genotype of MAO gene that the patients have are likely to be most susceptible to the symptoms of fibromyalgia?

Authors:  Savaş Gürsoy; Emin Erdal; Melek Sezgin; Ibrahim Omer Barlas; Ali Aydeniz; Belgin Alaşehirli; Günşah Sahin
Journal:  Rheumatol Int       Date:  2007-09-20       Impact factor: 2.631

8.  The relationship between a common catechol-O-methyltransferase (COMT) polymorphism val(158) met and fibromyalgia.

Authors:  H Cohen; L Neumann; Y Glazer; R P Ebstein; D Buskila
Journal:  Clin Exp Rheumatol       Date:  2009 Sep-Oct       Impact factor: 4.473

9.  DRD3 Ser9Gly polymorphism is related to thermal pain perception and modulation in chronic widespread pain patients and healthy controls.

Authors:  Stéphane Potvin; Annie Larouche; Edith Normand; Juliana Barcellos de Souza; Isabelle Gaumond; Sylvain Grignon; Serge Marchand
Journal:  J Pain       Date:  2009-05-23       Impact factor: 5.820

10.  No association between chronic musculoskeletal complaints and Val158Met polymorphism in the Catechol-O-methyltransferase gene. The HUNT study.

Authors:  Knut Hagen; Elin Pettersen; Lars Jacob Stovner; Frank Skorpen; John-Anker Zwart
Journal:  BMC Musculoskelet Disord       Date:  2006-05-04       Impact factor: 2.362

View more
  42 in total

1.  [Etiology and pathophysiology of fibromyalgia syndrome].

Authors:  C Sommer; W Häuser; M Burgmer; R Engelhardt; K Gerhold; F Petzke; T Schmidt-Wilcke; M Späth; T Tölle; N Uçeyler; H Wang; A Winkelmann; K Thieme
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

Review 2.  Fibromyalgia: mechanisms and potential impact of the ACR 2010 classification criteria.

Authors:  John McBeth; Matthew R Mulvey
Journal:  Nat Rev Rheumatol       Date:  2012-01-24       Impact factor: 20.543

3.  Association between the COMT Val158Met polymorphism and fibromyalgia susceptibility and fibromyalgia impact questionnaire score: a meta-analysis.

Authors:  Young Ho Lee; Jae-Hoon Kim; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2014-06-21       Impact factor: 2.631

Review 4.  Selective serotonin reuptake inhibitors for fibromyalgia syndrome.

Authors:  Brian Walitt; Gerard Urrútia; María Betina Nishishinya; Sarah E Cantrell; Winfried Häuser
Journal:  Cochrane Database Syst Rev       Date:  2015-06-05

5.  Profile of circulating microRNAs in fibromyalgia and their relation to symptom severity: an exploratory study.

Authors:  Jan L Bjersing; Maria I Bokarewa; Kaisa Mannerkorpi
Journal:  Rheumatol Int       Date:  2014-09-28       Impact factor: 2.631

6.  Association between low bone mineral density and fibromyalgia: a meta-analysis.

Authors:  Young Ho Lee; Gwan Gyu Song
Journal:  Clin Rheumatol       Date:  2017-05-23       Impact factor: 2.980

7.  Family-based clinical associations and functional characterization of the serotonin 2A receptor gene (HTR2A) in autism spectrum disorder.

Authors:  Ryan M Smith; Wesley Banks; Emily Hansen; Wolfgang Sadee; Gail E Herman
Journal:  Autism Res       Date:  2014-04-17       Impact factor: 5.216

Review 8.  Oral nonsteroidal anti-inflammatory drugs for fibromyalgia in adults.

Authors:  Sheena Derry; Philip J Wiffen; Winfried Häuser; Martin Mücke; Thomas Rudolf Tölle; Rae F Bell; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2017-03-27

Review 9.  Oxycodone for pain in fibromyalgia in adults.

Authors:  Helen Gaskell; R Andrew Moore; Sheena Derry; Cathy Stannard
Journal:  Cochrane Database Syst Rev       Date:  2016-09-01

10.  Multiple regulatory variants modulate expression of 5-hydroxytryptamine 2A receptors in human cortex.

Authors:  Ryan M Smith; Audrey C Papp; Amy Webb; Cara L Ruble; Leanne M Munsie; Laura K Nisenbaum; Joel E Kleinman; Barbara K Lipska; Wolfgang Sadee
Journal:  Biol Psychiatry       Date:  2012-11-13       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.